Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease.
Progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1) is a recessively inherited neurodegenerative disease caused by loss-of-function mutations in the gene encoding cystatin B, a cysteine protease inhibitor. Mice with disruptions in this gene display myoclonic seizures, progressive ataxia, and cerebellar pathology closely paralleling EPMI in humans. To provide further insight into our understanding of EPM1, we report pathological findings in brains from cystatin B-deficient mice. In addition to confirming the loss of cerebellar granular cell neurons by apoptosis, we identified additional neuronal apoptosis in young mutant mice (3-4 months old) within the hippocampal formation and entorhinal cortex. In older mutant mice (16-18 months old), there was also gliosis most marked in the presubiculum and parasubiculum of the hippocampal formation, as well as the entorhinal cortex, neocortex, and striatum. Furthermore, widespread white matter gliosis was also noted, which may be a secondary phenomenon. Within the cerebral cortex, cellular atrophy was a prominent finding in the superficial neurons of the prosubiculum. Finally, we show that mutant mice in either a "seizure-prone" or "seizure-resistant" genetic background display similar neuropathological changes. These findings indicate that neuronal atrophy is an important consequence of cystatin-B deficiency independent of seizure events, suggesting a physiological role for this protein in the maintenance of normal neuronal structure.
Shannon
Patrick
P
Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
Pennacchio
Len A
LA
Houseweart
Megan K
MK
Minassian
Berge A
BA
Myers
Richard M
RM
D000818:Animals; D001835:Body Weight; D001921:Brain / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D055313:Cystatin B; D015891:Cystatins / Q000172:deficiency* / Q000502:physiology; D015853:Cysteine Proteinase Inhibitors / Q000172:deficiency*; D004195:Disease Models, Animal; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006801:Humans; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D009929:Organ Size; D010641:Phenotype; D020194:Unverricht-Lundborg Syndrome / Q000473:pathology* / Q000503:physiopathology*
C524994:CSTB protein, human; C524992:Cstb protein, mouse; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors; D005904:Glial Fibrillary Acidic Protein; D055313:Cystatin B